Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, May 2000, p. 468-476, Vol. 7, No. 3
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Are the Enzyme Immunoassays for Antibodies to
Pneumococcal Capsular Polysaccharides Serotype Specific?
Anu
Soininen,1,*
Germie
van den Dobbelsteen,2
Lukas
Oomen,2 and
Helena
Käyhty1
Department of Vaccines, National Public
Health Institute (KTL), Helsinki, Finland,1 and
Laboratory for Vaccine Research, National Institute of Public
Health and the Environment (RIVM), Bilthoven, The
Netherlands2
Received 5 November 1999/Returned for modification 7 January
2000/Accepted 9 March 2000
The specificity of antibody binding to pneumococcal capsular
polysaccharides (Pnc PSs) measured by enzyme immunoassay (EIA) was
studied by inhibition of antibody binding by homologous and heterologous PSs. We found extensive cross-reactivity of antibody binding to type 6B, 19F, and 23F PSs but not to type 14 PS, even after
treatment with cell wall PS (CPS). The cross-reactive antibody was
highly prevalent in sera of infants and adults with naturally acquired
antibody, but not in sera of infants and adults immunized with
pneumococcal vaccines. However, a type 11A antibody response was seen
after vaccination with heterologous PSs. Monoclonal antibodies prepared
against a type 6B PS-tetanus toxoid conjugate recognized also other
than the specific type of PS in the EIA, implying the possible
existence of a cross-reactive epitope. Remarkable differences in
specificity among type 6B PS preparations from different manufacturers were found. Moreover, different lots of type 11A PS from the same manufacturer showed differences in specificity. The results suggest that some Pnc PS preparations may contain cross-reactive epitopes or
impurities, other than CPS, that are common to many types of Pnc PS.
The specificity of antibodies, especially in sera from nonimmunized
subjects, measured by EIA can be questioned.
*
Corresponding author. Mailing address: Laboratory of
Vaccine Immunology, Department of Vaccines, National Public Health
Institute, Mannerheimintie 166, 00300 Helsinki, Finland. Phone: 358 9 4744 8588. Fax: 358 9 4744 8599. E-mail:
anu.soininen{at}ktl.fi.
Clinical and Diagnostic Laboratory Immunology, May 2000, p. 468-476, Vol. 7, No. 3
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rose, M. A., Schubert, R., Strnad, N., Zielen, S.
(2005). Priming of Immunological Memory by Pneumococcal Conjugate Vaccine in Children Unresponsive to 23-Valent Polysaccharide Pneumococcal Vaccine. CVI
12: 1216-1222
[Abstract]
[Full Text]
-
Inostroza, J., Villanueva, S., Mason, K., Leiva, L. E., Sorensen, R. U.
(2005). Effects of Absorption with Pneumococcal Type 22F Polysaccharide on Maternal, Cord Blood, and Infant Immunoglobulin G Antipneumococcal Polysaccharide Antibodies. CVI
12: 722-726
[Abstract]
[Full Text]
-
Sikkema, D. J., Ziembiec, N. A., Jones, T. R., Hildreth, S. W., Madore, D. V., Quataert, S. A.
(2005). Assignment of Weight-Based Immunoglobulin G1 (IgG1) and IgG2 Units in Antipneumococcal Reference Serum Lot 89-S(F) for Pneumococcal Polysaccharide Serotypes 1, 4, 5, 7F, 9V, and 18C. CVI
12: 218-223
[Abstract]
[Full Text]
-
Feikin, D. R., Elie, C. M., Goetz, M. B., Lennox, J. L., Carlone, G. M., Romero-Steiner, S., Holder, P. F., O'Brien, W. A., Whitney, C. G., Butler, J. C., Breiman, R. F.
(2004). Specificity of the Antibody Response to the Pneumococcal Polysaccharide and Conjugate Vaccines in Human Immunodeficiency Virus-Infected Adults. CVI
11: 137-141
[Abstract]
[Full Text]
-
Biagini, R. E., Schlottmann, S. A., Sammons, D. L., Smith, J. P., Snawder, J. C., Striley, C. A. F., MacKenzie, B. A., Weissman, D. N.
(2003). Method for Simultaneous Measurement of Antibodies to 23 Pneumococcal Capsular Polysaccharides. CVI
10: 744-750
[Abstract]
[Full Text]
-
Artz, A. S., Ershler, W. B., Longo, D. L.
(2003). Pneumococcal Vaccination and Revaccination of Older Adults. Clin. Microbiol. Rev.
16: 308-318
[Abstract]
[Full Text]
-
Soininen, A., Karpala, M., Wahlman, S.-L., Lehtonen, H., Kayhty, H.
(2002). Specificities and Opsonophagocytic Activities of Antibodies to Pneumococcal Capsular Polysaccharides in Sera of Unimmunized Young Children. CVI
9: 1032-1038
[Abstract]
[Full Text]
-
Jansen, W. T. M., Vakevainen-Anttila, M., Kayhty, H., Nahm, M., Bakker, N., Verhoef, J., Snippe, H., Verheul, A. F. M.
(2001). Comparison of a Classical Phagocytosis Assay and a Flow Cytometry Assay for Assessment of the Phagocytic Capacity of Sera from Adults Vaccinated with a Pneumococcal Conjugate Vaccine. CVI
8: 245-250
[Abstract]
[Full Text]
-
Concepcion, N. F., Frasch, C. E.
(2001). Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent Assay. CVI
8: 266-272
[Abstract]
[Full Text]
-
Jansen, W. T. M., Hogenboom, S., Thijssen, M. J. L., Kamerling, J. P., Vliegenthart, J. F. G., Verhoef, J., Snippe, H., Verheul, A. F. M.
(2001). Synthetic 6B Di-, Tri-, and Tetrasaccharide-Protein Conjugates Contain Pneumococcal Type 6A and 6B Common and 6B- Specific Epitopes That Elicit Protective Antibodies in Mice. Infect. Immun.
69: 787-793
[Abstract]
[Full Text]